FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904996155> ?p ?o ?g. }

• W2904996155 endingPage "273" @default.
• W2904996155 startingPage "273" @default.
• W2904996155 abstract "Nail delivery has interest for local treatment of nail diseases. Nevertheless, the low permeability of drugs in the nail plaque precludes the efficacy of local treatments. The use of penetration enhancers can increase drug permeability and improve the efficacy of the treatment of nail pathologies. In this work, different chemical substances have been evaluated as potential penetration enhancers. With this aim, the effect of different substances such as sodium lauryl sulfate (SLS), polyethylene glycol 300 (PEG 300), carbocysteine, N-acetylcysteine, lactic acid, potassium phosphate, Labrasol® and Labrafil® in the microstructure, nail surface and drug permeability has been evaluated. The models obtained by mercury intrusion porosimetry and PoreXpert™ software show a more porous structure in nails treated with different enhancers. Permeation studies with bovine hooves and nails revealed that all the hydroalcoholic lacquers developed, and particularly those prepared with SLS, provide better nail penetration of the drugs ciclopirox olamine and clobetasol propionate. Results have shown that the increase of the drug penetration in the nail is caused by the formation of a porous random microstructure and by the decrease of the contact angle between lacquers and the surface or the nail plaque. The presence of SLS produces an improvement in the spreading of the solution on the nail surface and promotes the penetration of the solution into the nail pores. The hydroalcoholic lacquer, elaborated with cyclodextrin/poloxamer soluble polypseudorotaxane and sodium lauryl sulfate as an enhancer, allowed the rate of diffusion and penetration of the active ingredient within the nail to be significantly higher than obtained with the reference lacquers when using either ciclopirox olamine or clobetasol propionate as the active ingredient." @default.
• W2904996155 created "2018-12-22" @default.
• W2904996155 creator A5006589037 @default.
• W2904996155 creator A5018744809 @default.
• W2904996155 creator A5052947429 @default.
• W2904996155 creator A5067612645 @default.
• W2904996155 creator A5077044722 @default.
• W2904996155 date "2018-12-13" @default.
• W2904996155 modified "2023-10-08" @default.
• W2904996155 title "Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers" @default.
• W2904996155 cites W1625126713 @default.
• W2904996155 cites W1933620746 @default.
• W2904996155 cites W1968067811 @default.
• W2904996155 cites W1974050866 @default.
• W2904996155 cites W1982516977 @default.
• W2904996155 cites W1986388662 @default.
• W2904996155 cites W1990195226 @default.
• W2904996155 cites W1990853343 @default.
• W2904996155 cites W1997086695 @default.
• W2904996155 cites W2000162584 @default.
• W2904996155 cites W2010288241 @default.
• W2904996155 cites W2012090511 @default.
• W2904996155 cites W2015376943 @default.
• W2904996155 cites W2018831894 @default.
• W2904996155 cites W2023214486 @default.
• W2904996155 cites W2023788932 @default.
• W2904996155 cites W2025115045 @default.
• W2904996155 cites W2033897328 @default.
• W2904996155 cites W2045908852 @default.
• W2904996155 cites W2046365958 @default.
• W2904996155 cites W2053201770 @default.
• W2904996155 cites W2054485411 @default.
• W2904996155 cites W2063395504 @default.
• W2904996155 cites W2063962080 @default.
• W2904996155 cites W2073049453 @default.
• W2904996155 cites W2073128190 @default.
• W2904996155 cites W2075165234 @default.
• W2904996155 cites W2078281876 @default.
• W2904996155 cites W2089831809 @default.
• W2904996155 cites W2127719239 @default.
• W2904996155 cites W2156809988 @default.
• W2904996155 cites W2158251029 @default.
• W2904996155 cites W2166448744 @default.
• W2904996155 cites W2301245685 @default.
• W2904996155 cites W2324661394 @default.
• W2904996155 cites W2417458494 @default.
• W2904996155 cites W2528534302 @default.
• W2904996155 cites W2792607011 @default.
• W2904996155 cites W2889955623 @default.
• W2904996155 cites W81990505 @default.
• W2904996155 cites W98560680 @default.
• W2904996155 doi "https://doi.org/10.3390/pharmaceutics10040273" @default.
• W2904996155 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6321522" @default.
• W2904996155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30551601" @default.
• W2904996155 hasPublicationYear "2018" @default.
• W2904996155 type Work @default.
• W2904996155 sameAs 2904996155 @default.
• W2904996155 citedByCount "22" @default.
• W2904996155 countsByYear W29049961552019 @default.
• W2904996155 countsByYear W29049961552020 @default.
• W2904996155 countsByYear W29049961552021 @default.
• W2904996155 countsByYear W29049961552022 @default.
• W2904996155 countsByYear W29049961552023 @default.
• W2904996155 crossrefType "journal-article" @default.
• W2904996155 hasAuthorship W2904996155A5006589037 @default.
• W2904996155 hasAuthorship W2904996155A5018744809 @default.
• W2904996155 hasAuthorship W2904996155A5052947429 @default.
• W2904996155 hasAuthorship W2904996155A5067612645 @default.
• W2904996155 hasAuthorship W2904996155A5077044722 @default.
• W2904996155 hasBestOaLocation W29049961551 @default.
• W2904996155 hasConcept C127413603 @default.
• W2904996155 hasConcept C16005928 @default.
• W2904996155 hasConcept C178790620 @default.
• W2904996155 hasConcept C185592680 @default.
• W2904996155 hasConcept C2776745646 @default.
• W2904996155 hasConcept C2776964284 @default.
• W2904996155 hasConcept C2780564577 @default.
• W2904996155 hasConcept C41625074 @default.
• W2904996155 hasConcept C42475967 @default.
• W2904996155 hasConcept C43617362 @default.
• W2904996155 hasConcept C50670333 @default.
• W2904996155 hasConcept C55493867 @default.
• W2904996155 hasConcept C71924100 @default.
• W2904996155 hasConcept C80107235 @default.
• W2904996155 hasConceptScore W2904996155C127413603 @default.
• W2904996155 hasConceptScore W2904996155C16005928 @default.
• W2904996155 hasConceptScore W2904996155C178790620 @default.
• W2904996155 hasConceptScore W2904996155C185592680 @default.
• W2904996155 hasConceptScore W2904996155C2776745646 @default.
• W2904996155 hasConceptScore W2904996155C2776964284 @default.
• W2904996155 hasConceptScore W2904996155C2780564577 @default.
• W2904996155 hasConceptScore W2904996155C41625074 @default.
• W2904996155 hasConceptScore W2904996155C42475967 @default.
• W2904996155 hasConceptScore W2904996155C43617362 @default.
• W2904996155 hasConceptScore W2904996155C50670333 @default.
• W2904996155 hasConceptScore W2904996155C55493867 @default.
• W2904996155 hasConceptScore W2904996155C71924100 @default.
• W2904996155 hasConceptScore W2904996155C80107235 @default.

• next